Recital 4, Regulation (EU) 2024/2587

In forcesince 2 Oct 2024

In its opinion, the Agency concludes that the proposed differences between ‘Divosan PAA products’ and the related reference biocidal product family ‘Airedale PAA product family’ are limited to information which can be the subject of an administrative change in accordance with Article 11 of Commission Implementing Regulation (EU) No 354/2013 [Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj).], and that based on the assessment of the related reference biocidal product family ‘Airedale PAA product family’ and subject to compliance with the draft SPC, ‘Divosan PAA products’ meets the conditions laid down in Article 19(1) and (6) of Regulation (EU) No 528/2012.